| NCT03816176 |
A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants |
https://ClinicalTrials.gov/show/NCT03816176 |
Active, not recruiting |
Astellas Pharma Inc |
2022-02-28 |
| NCT03378479 |
Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT03378479 |
Recruiting |
Universitaire Ziekenhuizen Leuven |
2019-03-30 |
| NCT03340597 |
Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03340597 |
Completed |
F2G Ltd. |
2018-04-13 |
| NCT02440009 |
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT02440009 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2018-12-31 |
| NCT03133299 |
A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma |
https://ClinicalTrials.gov/show/NCT03133299 |
Completed |
Postgraduate Institute of Medical Education and Research |
2018-06-30 |
| NCT03059992 |
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment |
https://ClinicalTrials.gov/show/NCT03059992 |
Recruiting |
Scynexis, Inc. |
2021-09-30 |
| NCT02955966 |
PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT02955966 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-08-31 |
| NCT02851680 |
Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia. |
https://ClinicalTrials.gov/show/NCT02851680 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-05-31 |
| NCT02737371 |
Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02737371 |
Completed |
F2G Ltd. |
2017-05-22 |
| NCT02730442 |
Study of Potential for Interaction of Fluconazole With F901318 |
https://ClinicalTrials.gov/show/NCT02730442 |
Completed |
F2G Ltd. |
2016-06-30 |
| NCT02715570 |
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945 |
https://ClinicalTrials.gov/show/NCT02715570 |
Completed |
Pulmocide Ltd |
2018-04-27 |
| NCT02680808 |
Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe |
https://ClinicalTrials.gov/show/NCT02680808 |
Completed |
F2G Ltd. |
2016-06-30 |
| NCT02631954 |
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02631954 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-10-31 |
| NCT02394483 |
Single Ascending Oral Dose Study of F901318 |
https://ClinicalTrials.gov/show/NCT02394483 |
Completed |
F2G Ltd. |
2016-09-30 |
| NCT02342574 |
F901318 Multiple Ascending Dose Study |
https://ClinicalTrials.gov/show/NCT02342574 |
Completed |
F2G Ltd. |
2016-09-30 |
| NCT02273661 |
Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). |
https://ClinicalTrials.gov/show/NCT02273661 |
Completed |
Poitiers University Hospital |
2019-06-28 |
| NCT02180165 |
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) |
https://ClinicalTrials.gov/show/NCT02180165 |
Completed |
Merck Sharp & Dohme Corp. |
2018-01-24 |
| NCT02142153 |
F901318 Single Ascending Dose Study in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02142153 |
Completed |
F2G Ltd. |
2014-10-31 |
| NCT01857479 |
A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT01857479 |
Completed |
Postgraduate Institute of Medical Education and Research |
2015-06-30 |
| NCT01782131 |
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) |
https://ClinicalTrials.gov/show/NCT01782131 |
Completed |
Merck Sharp & Dohme Corp. |
2019-07-10 |
| NCT01621321 |
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT01621321 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-04-30 |
| NCT01615809 |
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia |
https://ClinicalTrials.gov/show/NCT01615809 |
Completed |
Fundació Sant Joan de Déu |
2013-07-31 |
| NCT01576315 |
ATCF (Azole Therapy in Cystic Fibrosis) |
https://ClinicalTrials.gov/show/NCT01576315 |
Completed |
Rennes University Hospital |
2015-10-31 |
| NCT01383993 |
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection |
https://ClinicalTrials.gov/show/NCT01383993 |
Completed |
Pfizer |
2013-05-31 |
| NCT01321827 |
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT01321827 |
Completed |
Postgraduate Institute of Medical Education and Research |
2013-03-31 |
| NCT04227483 |
Deflazacort vs. Prednisolone in Acute-stage ABPA |
https://ClinicalTrials.gov/show/NCT04227483 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2022-01-14 |
| NCT04108962 |
Benralizumab in the Treatment of Patients With Severe Asthma With ABPA |
https://ClinicalTrials.gov/show/NCT04108962 |
Recruiting |
Baylor Research Institute |
2022-04-30 |
| NCT03920527 |
Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA |
https://ClinicalTrials.gov/show/NCT03920527 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2021-01-31 |
| NCT03828773 |
PTX3-targeted Antifungal Prophylaxis |
https://ClinicalTrials.gov/show/NCT03828773 |
Recruiting |
Centre Hospitalier Universitaire Vaudois |
2022-07-31 |
| NCT03731169 |
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels |
https://ClinicalTrials.gov/show/NCT03731169 |
Recruiting |
University Health Network, Toronto |
2019-06-30 |
| NCT03717623 |
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants |
https://ClinicalTrials.gov/show/NCT03717623 |
Recruiting |
Melbourne Health |
2020-06-30 |
| NCT03672292 |
Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT03672292 |
Recruiting |
Scynexis, Inc. |
2020-09-30 |
| NCT03656081 |
Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole |
https://ClinicalTrials.gov/show/NCT03656081 |
Recruiting |
Poitiers University Hospital |
2021-06-30 |
| NCT01259336 |
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT01259336 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-06-30 |
| NCT01222273 |
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT01222273 |
Completed |
University of Pittsburgh |
2013-09-30 |
| NCT01165320 |
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) |
https://ClinicalTrials.gov/show/NCT01165320 |
Completed |
Merck Sharp & Dohme Corp. |
2013-09-17 |
| NCT01080651 |
Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole |
https://ClinicalTrials.gov/show/NCT01080651 |
Completed |
Seoul National University Hospital |
2009-03-31 |
| NCT00974766 |
Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT00974766 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-03-31 |
| NCT00940017 |
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00940017 |
Completed |
Pfizer |
2008-10-31 |
| NCT04267497 |
Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) |
https://ClinicalTrials.gov/show/NCT04267497 |
Recruiting |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2022-06-30 |
| NCT02808741 |
Evaluation of Immediate Release Tablet |
https://ClinicalTrials.gov/show/NCT02808741 |
Completed |
F2G Ltd. |
2016-11-30 |
| NCT01710930 |
Protocol TARC-ABPA |
https://ClinicalTrials.gov/show/NCT01710930 |
Completed |
Nantes University Hospital |
2017-09-21 |
| NCT04218851 |
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104) |
https://ClinicalTrials.gov/show/NCT04218851 |
Recruiting |
Merck Sharp & Dohme Corp. |
2023-02-06 |
| NCT04229303 |
Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects |
https://ClinicalTrials.gov/show/NCT04229303 |
Recruiting |
Zambon SpA |
2020-07-31 |
| NCT00784368 |
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection |
https://ClinicalTrials.gov/show/NCT00784368 |
Completed |
Janssen Pharmaceutical K.K. |
2009-04-30 |
| NCT00717860 |
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00717860 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT00647907 |
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections |
https://ClinicalTrials.gov/show/NCT00647907 |
Completed |
Pfizer |
NA |
| NCT00634049 |
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi |
https://ClinicalTrials.gov/show/NCT00634049 |
Completed |
Astellas Pharma Inc |
2014-01-03 |
| NCT00531479 |
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00531479 |
Completed |
Pfizer |
2011-04-30 |
| NCT00501098 |
Prophylaxis of Fungal Invasive Infections in Leukemia |
https://ClinicalTrials.gov/show/NCT00501098 |
Completed |
Northern Italy Leukemia Group |
2008-12-31 |
| NCT00412893 |
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00412893 |
Completed |
Astellas Pharma Inc |
2013-03-28 |
| NCT00404092 |
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00404092 |
Completed |
University of Cologne |
2009-10-31 |
| NCT00391014 |
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT00391014 |
Completed |
PETHEMA Foundation |
2008-12-31 |
| NCT00361517 |
To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early |
https://ClinicalTrials.gov/show/NCT00361517 |
Completed |
Singapore General Hospital |
2007-10-30 |
| NCT00334412 |
COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00334412 |
Completed |
Gilead Sciences |
NA |
| NCT00263315 |
Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00263315 |
Completed |
Erasmus Medical Center |
NA |
| NCT00163722 |
A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients |
https://ClinicalTrials.gov/show/NCT00163722 |
Completed |
Bayside Health |
2011-01-31 |
| NCT00159822 |
Voriconazole For Chronic Bronchopulmonary Aspergillosis |
https://ClinicalTrials.gov/show/NCT00159822 |
Completed |
Pfizer |
2008-12-31 |
| NCT00158730 |
Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment |
https://ClinicalTrials.gov/show/NCT00158730 |
Completed |
Gilead Sciences |
NA |
| NCT00110045 |
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00110045 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2008-03-31 |
| NCT00003031 |
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis |
https://ClinicalTrials.gov/show/NCT00003031 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-10-31 |
| NCT00082524 |
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) |
https://ClinicalTrials.gov/show/NCT00082524 |
Completed |
Merck Sharp & Dohme Corp. |
2007-07-31 |
| NCT00076869 |
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) |
https://ClinicalTrials.gov/show/NCT00076869 |
Completed |
Merck Sharp & Dohme Corp. |
2004-09-30 |
| NCT00059878 |
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections |
https://ClinicalTrials.gov/show/NCT00059878 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005912 |
Voriconazole to Prevent Systemic Fungal Infections in Children |
https://ClinicalTrials.gov/show/NCT00005912 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001937 |
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients |
https://ClinicalTrials.gov/show/NCT00001937 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001810 |
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00001810 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001646 |
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00001646 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037206 |
A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). |
https://ClinicalTrials.gov/show/NCT00037206 |
Completed |
Pfizer |
NA |
| NCT00036166 |
Study of FK463 for the Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00036166 |
Completed |
Astellas Pharma Inc |
2002-01-31 |
| NCT00005668 |
A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma |
https://ClinicalTrials.gov/show/NCT00005668 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |